[Get Solution]Drug Repurposing in COVID-19
November 22nd, 2021
The aim of this review is to describe regulatory and pharmacological aspects of drug repurposing and to identify drugs proposed for repurposing in COVID-19 based on the evidence to support their use in the treatment of this disease.The challenges of the correct interpretation of existing pre-clinical/clinical evidence as well as the generation of new evidence concerning drug repurposing in COVID-19 will also be discussed.
Struggling to find relevant content or pressed for time? – Don’t worry, we have a team of professionals to help you on
[Get Solution]Drug Repurposing in COVID-19
Get a 15% Discount on this Paper
So much stress and so little time? We’ve got you covered. Get your paper proofread, edited or written from scratch within the tight deadline.